| Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS). | |
| | |
MedLine Citation:
|
PMID: 16968826 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Following the marketing ban of ephedra-containing supplements in April 2004, many manufacturers substituted the herb Citrus aurantium for ephedra and marketed the products as "ephedra-free" supplements. Extracts of C. aurantium contain synephrine, a sympathomimetic alkaloid. OBJECTIVE: To determine the prevalence of consumption of dietary supplements containing C. aurantium in California during 2004. METHODS: We used the 2004 California Behavioral Risk Factor Surveillance Survey to determine the prevalence of consumption of dietary supplements containing C. aurantium in California during 2004. RESULTS: Two percent (n = 70) of the 4140 survey respondents reported taking a dietary supplement containing C. aurantium in the previous year. Reasons stated included energy enhancement, weight loss, and appetite suppression. Compared with nonusers, users were more likely to report being single, aged 18-34 years, and Hispanic; consuming 3 or more alcoholic drinks on days that they imbibed; and having a heavier body mass index. Among the 5 users who reported experiencing an adverse event that they attributed to the supplement, 3 indicated that the severity was mild. CONCLUSIONS: Given that supplements containing ephedra were banned in April 2004, the results from this study may serve as a baseline estimate against which future studies of the use of C. aurantium products may be compared. |
| | |
Authors:
|
Karl C Klontz; Babgaleh B Timbo; Debra Street |
Related Documents
:
|
3768116 - Neurovascular anatomy and elbow arthroscopy: inherent risks. 9544546 - Death investigation in canada. 21112356 - Is pain patients' psychophysiological arousal while watching their videotaped medical i... 1495876 - The focused physical examination. should checkups be tailor-made? 10254206 - Malpractice in the '80s -- what lies ahead, what can be done. 16696256 - Multiple user considerations and their implications in medical error reporting system d... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2006-09-12 |
Journal Detail:
|
Title: The Annals of pharmacotherapy Volume: 40 ISSN: 1542-6270 ISO Abbreviation: Ann Pharmacother Publication Date: 2006 Oct |
Date Detail:
|
Created Date: 2006-09-27 Completed Date: 2006-11-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9203131 Medline TA: Ann Pharmacother Country: United States |
Other Details:
|
Languages: eng Pagination: 1747-51 Citation Subset: IM |
Affiliation:
|
Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, MD 20740-3835, USA. karl.klontz@cfsan.fda.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Appetite Regulation / drug effects Behavioral Risk Factor Surveillance System* California / epidemiology Citrus* / adverse effects Cross-Sectional Studies Dietary Supplements* / adverse effects Female Humans Male Middle Aged Risk Factors Socioeconomic Factors Weight Loss / drug effects |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitors.
Next Document: Oxcarbazepine use in essential tremor.